« Go Back

Varsha Dourado

Varsha joined Contineum in May 2021 and brings over 20 years of experience in biotechnology business development, alliance management, and corporate strategy. Her experience spans in- and out-license agreements, asset purchases and divestments, M&A and financing activities. She joined Contineum Therapeutics from Secura Bio, where she led business development efforts including the acquisition of Copiktra®, from Verastem Oncology. Varsha previously worked at Synthetic Genomics, Viking Pharmaceuticals, and Amylin Pharmaceuticals (acquired by BMS). Varsha holds an MBA in Technology Transfer and a Master of Science in Neuroscience.